For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Passage Bio Inc’s stock clocked out at $0.66, down -5.86% from its previous closing price of $0.70. In other words, the price has decreased by -$5.86 from its previous closing price. On the day, 0.43 million shares were traded. PASG stock price reached its highest trading level at $0.7899 during the session, while it also had its lowest trading level at $0.64.
Ratios:
To gain a deeper understanding of PASG’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.15 and its Current Ratio is at 5.15. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 03, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 08 ’25 when ORBIMED ADVISORS LLC sold 75,007 shares for $0.68 per share. The transaction valued at 51,005 led to the insider holds 7,257,845 shares of the business.
ORBIMED ADVISORS LLC sold 52,536 shares of PASG for $37,301 on Jan 07 ’25. The 10% Owner now owns 7,332,852 shares after completing the transaction at $0.71 per share. On Jan 06 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the 10% Owner of the company, sold 19,481 shares for $0.77 each. As a result, the insider received 15,000 and left with 7,385,388 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PASG now has a Market Capitalization of 40704648 and an Enterprise Value of -29166948.
Stock Price History:
The Beta on a monthly basis for PASG is 1.52, which has changed by -0.34752476 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, PASG has reached a high of $1.79, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -3.00%, while the 200-Day Moving Average is calculated to be -26.27%.
Shares Statistics:
It appears that PASG traded 746.06K shares on average per day over the past three months and 1220910 shares per day over the past ten days. A total of 61.77M shares are outstanding, with a floating share count of 51.56M. Insiders hold about 16.53% of the company’s shares, while institutions hold 44.02% stake in the company. Shares short for PASG as of 1730332800 were 1641302 with a Short Ratio of 2.28, compared to 1727654400 on 1701219. Therefore, it implies a Short% of Shares Outstanding of 1641302 and a Short% of Float of 3.19.
Earnings Estimates
The market rating of Passage Bio Inc (PASG) is currently shaped by the ongoing analysis conducted by 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.25 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$1.11 and -$1.11 for the fiscal current year, implying an average EPS of -$1.11. EPS for the following year is -$0.55, with 3.0 analysts recommending between -$0.3 and -$1.0.
